Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
29.52
+0.22 (0.75%)
Dec 5, 2025, 4:00 PM EST - Market closed
Alkermes Employees
Alkermes had 1,800 employees as of December 31, 2024. The number of employees decreased by 300 or -14.29% compared to the previous year.
Employees
1,800
Change (1Y)
-300
Growth (1Y)
-14.29%
Revenue / Employee
$845,188
Profits / Employee
$188,237
Market Cap
4.87B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALKS News
- 17 hours ago - Alkermes plc (ALKS) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Alkermes to Participate in Two Upcoming Investor Conferences - Business Wire
- 17 days ago - Alkermes raises offer for Avadel after Lundbeck bid - Reuters
- 17 days ago - Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc - PRNewsWire
- 18 days ago - Alkermes plc (ALKS) Shareholder/Analyst Call Transcript - Seeking Alpha
- 22 days ago - Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal - Benzinga
- 22 days ago - H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal - WSJ
- 22 days ago - Alkermes reviewing options after Lundbeck makes unsolicited bid for Avadel - Reuters